MX2013013341A - Compuestos utiles para prevenir o tratar el sindrome del intestino irritable y composiciones que los incluyen. - Google Patents

Compuestos utiles para prevenir o tratar el sindrome del intestino irritable y composiciones que los incluyen.

Info

Publication number
MX2013013341A
MX2013013341A MX2013013341A MX2013013341A MX2013013341A MX 2013013341 A MX2013013341 A MX 2013013341A MX 2013013341 A MX2013013341 A MX 2013013341A MX 2013013341 A MX2013013341 A MX 2013013341A MX 2013013341 A MX2013013341 A MX 2013013341A
Authority
MX
Mexico
Prior art keywords
bowel syndrome
irritable bowel
preventing
composition including
compound
Prior art date
Application number
MX2013013341A
Other languages
English (en)
Inventor
Do-Seung Kum
Keun-Ho Ryu
Hae-In Rhee
Hyo Jin Jeon
Yang Hae Park
Hyun-Joo Son
Bong-Yong Lee
Minseok Park
Won Suk Sun
Dongsun Min
Woong Sik Kim
Taek Su Kim
Eun-Ju Park
Hojin Namgung
Minseok Kang
Original Assignee
Sk Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Chemicals Co Ltd filed Critical Sk Chemicals Co Ltd
Publication of MX2013013341A publication Critical patent/MX2013013341A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona un compuesto de fórmula (I) o un profármaco del mismo, útil para tratar o prevenir el síndrome del intestino irritable y una composición que comprende el compuesto como ingrediente activo. La presente invención también proporciona un método para tratar o prevenir el síndrome del intestino irritable, el cual consiste en administrar una cantidad terapéutica o profilácticamente eficaz del compuesto o la composición a un individuo que necesite de tratamiento o prevención del síndrome del intestino irritable.
MX2013013341A 2011-05-18 2012-05-16 Compuestos utiles para prevenir o tratar el sindrome del intestino irritable y composiciones que los incluyen. MX2013013341A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110046999A KR20120129008A (ko) 2011-05-18 2011-05-18 과민성 장 증후군의 예방 또는 치료에 유용한 화합물 및 이를 포함하는 조성물
PCT/KR2012/003828 WO2012157949A2 (ko) 2011-05-18 2012-05-16 과민성 장 증후군의 예방 또는 치료에 유용한 화합물 및 이를 포함하는 조성물

Publications (1)

Publication Number Publication Date
MX2013013341A true MX2013013341A (es) 2014-04-16

Family

ID=47177480

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013341A MX2013013341A (es) 2011-05-18 2012-05-16 Compuestos utiles para prevenir o tratar el sindrome del intestino irritable y composiciones que los incluyen.

Country Status (10)

Country Link
US (1) US20140213647A1 (es)
EP (1) EP2711003A4 (es)
JP (1) JP2014513718A (es)
KR (1) KR20120129008A (es)
CN (1) CN103747783A (es)
BR (1) BR112013029604A2 (es)
CA (1) CA2836215A1 (es)
MX (1) MX2013013341A (es)
TW (1) TW201309287A (es)
WO (1) WO2012157949A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030080119A (ko) * 2002-04-03 2003-10-11 유종학 창출의 새로운 추출방법
MX2011012398A (es) * 2009-05-22 2012-02-28 Sk Chemicals Co Ltd Composicion para prevenir o tratar el sindrome de intestino irritable.

Also Published As

Publication number Publication date
EP2711003A2 (en) 2014-03-26
BR112013029604A2 (pt) 2016-12-13
EP2711003A4 (en) 2014-10-15
TW201309287A (zh) 2013-03-01
JP2014513718A (ja) 2014-06-05
CA2836215A1 (en) 2012-11-22
KR20120129008A (ko) 2012-11-28
WO2012157949A2 (ko) 2012-11-22
WO2012157949A3 (ko) 2013-03-21
CN103747783A (zh) 2014-04-23
US20140213647A1 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
WO2013122888A3 (en) Methods of treating bacterial infections
IN2014CN04907A (es)
IN2012DN00971A (es)
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
MX2012004780A (es) Inhibidores de akt.
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MD20140044A2 (ro) 2-Tiopirimidinone şi utilizarea lor pentru tratamentul afecţiunilor cardiovasculare
MX2014015197A (es) Tratamiento y prevencion de la enfermedad cardiovascular y trombosis.
MX2014015884A (es) Compuestos antivirales.
MX363478B (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
IN2015DN01230A (en) Pyrrolopyrazoles as n type calcium channel blockers
WO2012017321A3 (en) Treatment for dyslipidemia
MX2015001834A (es) Nuevos compuestos antibacterianos.
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
EA201491581A1 (ru) Везикулярные композиции
MX2015001254A (es) Composicion y metodo para impedir la decoloracion de composiciones que contienen piritiona.
MX2015001835A (es) Nuevos compuestos antibacterianos.
NZ610547A (en) Novel monensin derivatives for the treatment and prevention of protozoal infections
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
WO2011028890A3 (en) Compositions and methods for treatment of neuropathic pain
MX2015010790A (es) Derivados de anilina sustituidos con n-heteroarilo como antivirales de vhc.
MX2013013341A (es) Compuestos utiles para prevenir o tratar el sindrome del intestino irritable y composiciones que los incluyen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal